241 related articles for article (PubMed ID: 29263104)
21. Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
Auerbuch V; Golenbock DT; Isberg RR
PLoS Pathog; 2009 Dec; 5(12):e1000686. PubMed ID: 19997504
[TBL] [Abstract][Full Text] [Related]
22. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
23. Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice.
Meinzer U; Esmiol-Welterlin S; Barreau F; Berrebi D; Dussaillant M; Bonacorsi S; Chareyre F; Niwa-Kawakita M; Alberti C; Sterkers G; Villard C; Lesuffleur T; Peuchmaur M; Karin M; Eckmann L; Giovannini M; Ollendorff V; Wolf-Watz H; Hugot JP
PLoS One; 2008 Jul; 3(7):e2769. PubMed ID: 18648508
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
Tansini A; de Medeiros BM
Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
[TBL] [Abstract][Full Text] [Related]
25. Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection.
Zhang Y; Mena P; Romanov G; Bliska JB
Infect Immun; 2014 Jul; 82(7):3033-44. PubMed ID: 24799630
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
McPhee JB; Mena P; Zhang Y; Bliska JB
Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection.
Hohl TM; Rivera A; Lipuma L; Gallegos A; Shi C; Mack M; Pamer EG
Cell Host Microbe; 2009 Nov; 6(5):470-81. PubMed ID: 19917501
[TBL] [Abstract][Full Text] [Related]
28. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
[TBL] [Abstract][Full Text] [Related]
29. Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling.
Jung C; Meinzer U; Montcuquet N; Thachil E; Château D; Thiébaut R; Roy M; Alnabhani Z; Berrebi D; Dussaillant M; Pedruzzi E; Thenet S; Cerf-Bensussan N; Hugot JP; Barreau F
J Clin Invest; 2012 Jun; 122(6):2239-51. PubMed ID: 22565313
[TBL] [Abstract][Full Text] [Related]
30. Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.
Porte R; Van Maele L; Muñoz-Wolf N; Foligné B; Dumoutier L; Tabareau J; Cayet D; Gosset P; Jonckheere N; Van Seuningen I; Chabalgoity JA; Simonet M; Lamkanfi M; Renauld JC; Sirard JC; Carnoy C
Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27872237
[TBL] [Abstract][Full Text] [Related]
31. Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.
Carnoy C; Mullet C; Müller-Alouf H; Leteurtre E; Simonet M
Infect Immun; 2000 May; 68(5):2553-9. PubMed ID: 10768943
[TBL] [Abstract][Full Text] [Related]
32. Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T Cell responses to influenza A virus infection.
Lupfer C; Thomas PG; Kanneganti TD
J Virol; 2014 Aug; 88(16):8946-55. PubMed ID: 24872587
[TBL] [Abstract][Full Text] [Related]
33. Influence of PhoP and intra-species variations on virulence of Yersinia pseudotuberculosis during the natural oral infection route.
Pisano F; Heine W; Rosenheinrich M; Schweer J; Nuss AM; Dersch P
PLoS One; 2014; 9(7):e103541. PubMed ID: 25075520
[TBL] [Abstract][Full Text] [Related]
34. Cell type-specific effects of Yersinia pseudotuberculosis virulence effectors.
Fahlgren A; Westermark L; Akopyan K; Fällman M
Cell Microbiol; 2009 Dec; 11(12):1750-67. PubMed ID: 19681909
[TBL] [Abstract][Full Text] [Related]
35. The Tat Substrate SufI Is Critical for the Ability of Yersinia pseudotuberculosis To Cause Systemic Infection.
Avican U; Doruk T; Östberg Y; Fahlgren A; Forsberg Å
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28115509
[TBL] [Abstract][Full Text] [Related]
36. CD8 T cells regulate allergic contact dermatitis by modulating CCR2-dependent TNF/iNOS-expressing Ly6C+ CD11b+ monocytic cells.
Chong SZ; Tan KW; Wong FHS; Chua YL; Tang Y; Ng LG; Angeli V; Kemeny DM
J Invest Dermatol; 2014 Mar; 134(3):666-676. PubMed ID: 24061165
[TBL] [Abstract][Full Text] [Related]
37. Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation.
Bergsbaken T; Cookson BT
J Leukoc Biol; 2009 Nov; 86(5):1153-8. PubMed ID: 19734471
[TBL] [Abstract][Full Text] [Related]
38. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
Fisher ML; Castillo C; Mecsas J
Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
[TBL] [Abstract][Full Text] [Related]
39. γδ T cell IFNγ production is directly subverted by Yersinia pseudotuberculosis outer protein YopJ in mice and humans.
Chu TH; Khairallah C; Shieh J; Cho R; Qiu Z; Zhang Y; Eskiocak O; Thanassi DG; Kaplan MH; Beyaz S; Yang VW; Bliska JB; Sheridan BS
PLoS Pathog; 2021 Dec; 17(12):e1010103. PubMed ID: 34871329
[TBL] [Abstract][Full Text] [Related]
40. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
